Please provide your email address to receive an email when new articles are posted on . At 2-year follow-up, a septal occluder device was deemed safe and effective for transcatheter closure of atrial ...

Occlutech, a leading innovator of implants to treat structural heart disease today announced that it has obtained Japanese MHW approval for its dedicated Atrial Septal Defect Closure Device. The ...

A novel study by Canadian physicians reported that the BioSTAR biodegradable implant achieved comparable closure rates to the Amplatzer Septal Occluder in children with atrial septal defect. A novel ...

Expert Rev Cardiovasc Ther. 2007;5(6):1135-1146. Diagnosing a secundum ASD is more often than not incidental because the defect normally causes symptoms late in adult life. Echocardiography and MRI ...

This paper presents serial cardiac-catheterization data showing spontaneous functional closure of large symptomatic defects in 3 infants. One had an associated moderate-sized patent ductus arteriosus ...

The National Institute for Clinical Excellence is examining endovascular closure of atrial septal defect and will publish guidance on its safety and efficacy to the NHS in England, Wales and Scotland.

JAIPUR: In a first, the Sawai Man Singh (SMS) hospital doctors conducted open heart surgery without using cardiopulmonary bypass (CPB) for atrial septal defect (ASD) closure. CPB is a technique that ...

May 31, 2007 (Seattle, WA) - The pivotal trial of a new device approved for the percutaneous closure of atrial septal defects (ASD)--the HELEX septal occluder (WL Gore and Associates, Flagstaff, ...

An atrial septal defect of the secundum type is relatively common and occurs from failure of the septum secundum to develop. This results in a communication between the left and right atrium directly ...

An atrial septal defect is the persistence of a hole (the foramen ovale) in the wall (septum) between the right atrium and left atrium of the heart. The foramen ovale usually closes spontaneously ...